HKEX Stock Code: 01093English|繁體|简体
Home > Investor Relations > Announcements & Notices
Announcements & Notices
Dec
14
VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND CO-DEVELOPMENT AGREEMENT
Dec
12
VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AGREEMENT
Nov
23
UNAUDITED RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2016
Nov
21
INSIDE INFORMATION AND RESUMPTION OF TRADING
Nov
21
TRADING HALT
Nov
11
DATE OF BOARD MEETING
Aug
26
COMPLETION OF EXERCISE OF THE EXISTING SHARE OPTIONS
Aug
23
2016 INTERIM RESULTS ANNOUNCEMENT
Aug
11
DATE OF BOARD MEETING
Jun
27
CONTINUING CONNECTED TRANSACTIONS - LEASE AGREEMENTS
Jun
13
(1) COMPLETION OF THE ACQUISITION OF 93.18% EQUITY INTEREST IN CSPC SHENGXUE GLUCOSE CO., LTD. AND (2) CONTINUING CONNECTED TRANSACTIONS
Jun
06
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Jun
06
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES
May
30
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 30 MAY 2016
May
18
UNAUDITED RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2016
May
06
DATE OF BOARD MEETING
Apr
25
VOLUNTARY ANNOUNCEMENT - PRODUCT TECHNOLOGY LICENSING AGREEMENT
Apr
21
NOTICE OF ANNUAL GENERAL MEETING
Apr
20
VOLUNTARY ANNOUNCEMENT - THE GROUP'S CHEMICAL DRUG "BUTYLPHTHALIDE SOFT CAPSULES" WAS GRANTED CLINICAL TRIAL APPROVAL IN RELATION TO A NEW INDICATION FOR VASCULAR DEMENTIA
Apr
20
VOLUNTARY ANNOUNCEMENT-CLARIFICATION OF ARTICLES
Apr
14
CONNECTED TRANSACTION - ACQUISITION OF 93.18% EQUITY INTEREST IN CSPC SHENGXUE GLUCOSE CO., LTD.
Apr
08
NON-COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES
Mar
21
ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2015
Mar
09
DATE OF BOARD MEETING
Feb
25
VOLUNTARY ANNOUNCEMENT - THE GROUP'S ONCOLOGY DRUG "SKLB1028 CAPSULES" WAS GRANTED CLINICAL TRIAL APPROVAL
Feb
05
VOLUNTARY ANNOUNCEMENT - APPROVAL GRANTED FOR THE COMMENCEMENT OF CLINICAL TRIALS FOR THE GROUP'S PRODUCTS
Jan
11
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Jan
08
RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND NON-COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES

Please download the latest "Acrobat Reader" to view the PDF.

© Copyright 2025 CSPC Pharmaceutical Group Limited. All Rights Reserved.
Disclaimer